These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 26147331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
    Bhattarai S, Pippel J, Scaletti E, Idris R, Freundlieb M, Rolshoven G, Renn C, Lee SY, Abdelrahman A, Zimmermann H, El-Tayeb A, Müller CE, Sträter N.
    J Med Chem; 2020 Mar 26; 63(6):2941-2957. PubMed ID: 32045236
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
    Junker A, Renn C, Dobelmann C, Namasivayam V, Jain S, Losenkova K, Irjala H, Duca S, Balasubramanian R, Chakraborty S, Börgel F, Zimmermann H, Yegutkin GG, Müller CE, Jacobson KA.
    J Med Chem; 2019 Apr 11; 62(7):3677-3695. PubMed ID: 30895781
    [Abstract] [Full Text] [Related]

  • 5. Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
    Miki T, Miura T, Bünger R, Suzuki K, Sakamoto J, Shimamoto K.
    Am J Physiol; 1998 Oct 11; 275(4):H1329-37. PubMed ID: 9746483
    [Abstract] [Full Text] [Related]

  • 6. The metabolism of ecto-5'-nucleotidase (CD73) inhibitor-α,β-methylene adenosine diphosphate in BALB/c mice.
    Tomczyk M, Mierzejewska P, Slominska EM, Smolenski RT.
    Nucleosides Nucleotides Nucleic Acids; 2018 Oct 11; 37(12):709-716. PubMed ID: 30623751
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of small molecule sulfonic acids as ecto-5'-Nucleotidase inhibitors.
    Raza R, Saeed A, Lecka J, Sévigny J, Iqbal J.
    Med Chem; 2012 Nov 11; 8(6):1133-9. PubMed ID: 22741787
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Myocardial adenosine formation during hypoxia: effects of ecto-5'-nucleotidase inhibition.
    Headrick JP, Matherne GP, Berne RM.
    J Mol Cell Cardiol; 1992 Mar 11; 24(3):295-303. PubMed ID: 1625350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
    Ripphausen P, Freundlieb M, Brunschweiger A, Zimmermann H, Müller CE, Bajorath J.
    J Med Chem; 2012 Jul 26; 55(14):6576-81. PubMed ID: 22731815
    [Abstract] [Full Text] [Related]

  • 16. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C, Peyrottes S, Rabeson C, Cros-Perrial E, Géant PY, Chaloin L, Jordheim LP.
    Eur J Med Chem; 2018 Sep 05; 157():1051-1055. PubMed ID: 30176535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells.
    Rockenbach L, Bavaresco L, Fernandes Farias P, Cappellari AR, Barrios CH, Bueno Morrone F, Oliveira Battastini AM.
    Urol Oncol; 2013 Oct 05; 31(7):1204-11. PubMed ID: 22137869
    [Abstract] [Full Text] [Related]

  • 19. Reserpine attenuates interstitial adenosine-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo.
    Obata T, Yamanaka Y.
    Arch Biochem Biophys; 2000 Mar 15; 375(2):333-9. PubMed ID: 10700389
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.